ReviewCurrent oncology reports2023

Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.

Evan C Cumpston et al.PubMed ↗Publisher ↗

No numbers read from the abstract.